NasdaqGS - Nasdaq Real Time Price
USD
Gossamer Bio, Inc. (GOSS)
10.38
-0.31
(-2.90%)
At close: October 30 at 4:00:01 PM EDT
10.30
-0.08
(-0.78%)
After hours: October 30 at 6:20:59 PM EDT
News headlines
Powered by Yahoo ScoutGossamer Bio’s investment case remains centered on seralutinib, following its September NDA submissionfor pulmonary arterial hypertension (PAH). Analysts remain divided because the Phase 3 PROSERA study missed its primary endpoint, while regulatory progress could unlock additional financing. The latest reported market move was down 2.90% in the regular session on October 31, 2026.
